25 of the Best Urologists Near Me in Canton, MI

Muzammil Ahmed is a Urologist practicing medicine in Canton, Michigan. He has been practicing medicine for over 33 years. Dr. Ahmed is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urinary Tract Infection in Children, Ureteroscopy, and Prostatectomy. Dr. Ahmed is board certified in American Board Of Urology. Dr. Ahmed is currently accepting new patients.

Gregory Mcintosh is a Urologist practicing medicine in Livonia, Michigan. He has been practicing medicine for over 34 years. Dr. Mcintosh is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Hydronephrosis, Obstructive Uropathy, Bilateral Hydronephrosis, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Mcintosh is board certified in American Osteopathic Board Of Surgery. Dr. Mcintosh is currently accepting new patients.

Jeffrey Schock is a Urologist practicing medicine in Livonia, Michigan. He has been practicing medicine for over 32 years. Dr. Schock is highly rated in 49 conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Prostatectomy. Dr. Schock is board certified in American Osteopathic Board Of Surgery. Dr. Schock is currently accepting new patients.

Michael Hoff is a Urologist practicing medicine in Livonia, Michigan. He has been practicing medicine for over 28 years. Dr. Hoff is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Perirenal Abscess, Carbuncle, Ureteroscopy, and Prostatectomy. Dr. Hoff is board certified in American Osteopathic Board Of Surgery. Dr. Hoff is currently accepting new patients.

Vijay Kotha is a Urologist practicing medicine in Wayne, Michigan. He has been practicing medicine for over 27 years. Dr. Kotha is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Prostatectomy. Dr. Kotha is board certified in American Board Of Urology. Dr. Kotha is currently accepting new patients.

Michael Cher is a Urologist practicing medicine in Dearborn, Michigan. He has been practicing medicine for over 40 years. Dr. Cher is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Prostatectomy, and Ureteral Reconstruction. Dr. Cher is board certified in American Board Of Urology. Dr. Cher is currently accepting new patients.

James Steward is a Urologist practicing medicine in Canton, Michigan. He has been practicing medicine for over 13 years. Dr. Steward is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), Ureteroscopy, and Nephrectomy. Dr. Steward is board certified in American Board Of Urology. Dr. Steward is currently accepting new patients.

Katie Rosen is a Urologist practicing medicine in Livonia, Michigan. Dr. Rosen is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Stress Urinary Incontinence, Ureteroscopy, and Prostatectomy. Dr. Rosen is board certified in American Osteopathic Board Of Surgery. Dr. Rosen is currently accepting new patients.

Marcus Jamil is a Urologist practicing medicine in Plymouth, Michigan. Dr. Jamil is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Urethral Stricture, Nephrectomy, and Prostatectomy.

After graduating from the University of Leeds, Dr. Ghani completed basic surgical training in Edinburgh followed by urological surgery training in London. He was awarded a Master of Surgery thesis from the University of London for research on percutaneous renal stone surgery. Following completion of sub-specialist training in Endourology at the Stone Unit at Guy’s Hospital, London, Dr. Ghani was awarded The Urology Foundation Scholarship and undertook fellowship training in robotic surgery at the Vattikuti Urology Institute, Henry Ford Hospital, Detroit.He joined the University of Michigan in 2013 and leads the Endourology program at the Ann Arbor VA Healthcare System. He treats patients with kidney problems: stones, cancer and obstruction. Dr Ghani has authored over 200 peer-reviewed articles, and his research focuses on endoscopic stone surgery and quality improvement. Specifically, he has been advancing a Dusting technique for ureteroscopy and has extramural funding to study laser lithotripsy in the laboratory. He is the Course Director of the annual Developments in Ureteroscopic Stone Treatment (D.U.S.T.) symposium, an international meeting that has exposed hundreds of urologists to advanced ureteroscopy techniques. He is also the Course Director of the American Urological Association annual course, Dust or Bust.In addition, Dr Ghani serves as the Director of the Michigan Urological Surgery Improvement Collaborative (MUSIC), which is a consortium of 46 urology practices aiming to improve the quality of care for patients with prostate cancer, kidney stones, and kidney cancer. Within MUSIC, he is the principal investigator of two randomized clinical trials assessing patient health-related quality of life and healthcare use after ureteroscopy. Dr. Ghani has received numerous prizes for his presentations and research from the American Urological Association, Endourological Society, European Association of Urology, and has lectured and taught surgeons throughout the world. He is an Assistant Editor for the Journal of Urology and serves on the editorial board of Nature Reviews Urology. Dr. Ghani is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Urinary Tract Infection (UTI), Prostate Cancer, Lithotripsy, and Ureteroscopy.

Khaled Hafez is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Hafez is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Hafez is board certified in Urology.

Dr. Kraft is clinical associate professor in the Department of Urology at the University of Michigan and practices pediatric urology at C.S. Mott Children’s Hospital in Ann Arbor.She received her undergraduate degree from Harvard University and medical degree from Columbia University College of Physicians & Surgeons. She pursued her urology residency at Emory University School of Medicine in Atlanta, GA and then completed a fellowship in pediatric urology at the Children’s Hospital of Philadelphia. Dr. Kraft’s clinical interests include minimally invasive surgery and endourology in children, pediatric andrology, and disorders of sex development. She is currently pursuing clinical research in pediatric stone disease, uroradiology, spina bifida, and adolescent varicocele. With her interest in graduate medical education, Dr. Kraft serves as the Urology Residency Program Director and oversees urology postgraduate training at the University of Michigan. Dr. Kraft is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Undescended Testicle, Posterior Urethral Valves, Hypospadias, Lithotripsy, and Ureteroscopy.

Steven Lucas is a Urologist practicing medicine in Dearborn, Michigan. He has been practicing medicine for over 22 years. Dr. Lucas is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Hydronephrosis, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Ureteroscopy. Dr. Lucas is board certified in American Board Of Urology. Dr. Lucas is currently accepting new patients.

Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology at Vanderbilt University. Dr. Morgan is a translational surgeon-scientist, and his research spans the spectrum from preclinical laboratory-based research to prospective clinical trials. The primary focus of his laboratory is on identifying key pathways that predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop liquid biopsy approaches that can guide precision-based therapeutic strategies in real time, as well as ongoing research in renal cell carcinoma to identify genomic signatures for risk stratification.Dr. Morgan is currently an Associate Professor of Urology and has been at the University of Michigan since 2012. In addition to his research pursuits, he is a busy clinician and surgeon offering advanced robotic, laparoscopic, and open surgical approaches for patients with genitourinary malignancies. He has substantial expertise in the use and interpretation of molecular biomarkers, which can help guide individualized treatment choice for some patients.Beyond work, he loves his time enjoying the great town of Ann Arbor and beautiful state of Michigan with his wife, Wendy, and their two young boys. Whether camping in Petoskey, sitting on a beach in Grand Haven, or biking around the neighborhood in Ann Arbor, the Morgan family has quickly learned that life in the Midwest is hard to beat. Dr. Morgan is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Morgan is board certified in Urology.

Dr. Jeffery Montgomery's clinical interests include the diagnosis and management of bladder, prostate, and penile and testicular cancers. With his advanced training in urologic oncology and minimally invasive surgical techniques, such as robotic, laparoscopic and complex open surgery, he is able to deliver state-of-the-art care to his patients. He has expertise in state-of-the-art diagnostics for prostate cancer, including prostate MRI, fusion prostate biopsy, and transperineal standard and fusion prostate biopsies. He has extensive experience performing advanced robotic surgery, including prostatectomy, cystectomy with intra-corporeal urinary diversions, and inguinal lymph node dissections. Dr. Montgomery's research focuses on improving the quality and efficiency of urologic oncology disease management. Dr. Montgomery is a Michigan native and earned his undergraduate degree from the University of Michigan. He then went on to complete his medical education at the Columbia University College of Physicians and Surgeons in New York before finishing his Urology residency at the University of Michigan. He completed his urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Montgomery is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Montgomery is board certified in Urology.

Ganesh S. Palapattu, MD, FACS is The George F. and Sandy G. Valassis Professor and Chair of the Department of Urology. He joined the University of Michigan Department of Urology as Associate Professor and Chief of Urologic Oncology in the Fall of 2012. Prior to this he was the Chief of Urologic Oncology at Houston Methodist Hospital in Houston, Texas. Dr. Palapattu has held faculty appointments at the University of Rochester School of Medicine in Rochester, NY where he was also Assistant Residency Program Director and Weill Cornell Medical College/The Houston Methodist Hospital.Dr. Palapattu was born in Toronto, Canada where he developed a passion for street hockey. At the age of 9, his family moved to Houston, Texas where he picked up playing the French horn. Dr. Palapattu graduated from the University of Texas at Austin with a B.A. degree in the Humanities and subsequently attended Baylor College of Medicine. Dr. Palapattu received his surgical/urological training at the David Geffen School of Medicine at UCLA and further specialty training in urologic oncology at Johns Hopkins. He and his wife, Anu, whom he met at UT Austin, have 2 young children. The Palapattu family is enthusiastic about taking advantage of the many outdoor activities the Ann Arbor area affords.When not working, Dr. Palapattu enjoys spending time with his family, traveling and playing/watching sports. Go Blue!. Dr. Palapattu is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Palapattu is board certified in Urology.

Dr. Dauw received his medical degree from Loyola University in Chicago graduating Magna Cum Laude. He then completed a urology residency at The University of Michigan. Following this, he pursued subspecialty training in endourology with Dr. James Lingeman at Methodist Hospital in Indianapolis. His primary clinical interests include the medical and surgical management of kidney stones, in particular, endourological management of complex renal calculi. He is also one of few U.S. providers with expertise in holmium laser enucleation of the prostate (HoLEP), a state-of-the-art, minimally invasive surgical treatment for men with an enlarged prostate. His research interests focus on improving the quality of care for patients with kidney stones as well as understanding outcomes associated with commonly performed endourological surgeries. Dr. Dauw is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Perirenal Abscess, Folliculitis, Ureteroscopy, and Lithotripsy. Dr. Dauw is board certified in Urology.

Simpa S. Salami, M.D., M.P.H. is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his medical degree from the College of Medicine, University of Ibadan, Nigeria. Thereafter, he completed a Master of Public Health program at Harvard University, General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami’s clinical expertise is in the minimally invasive surgical treatment of prostate and kidney cancer. As a translational surgeon-scientist, his laboratory focuses on developing novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response. Dr. Salami’s lab collaborates with investigators all over the world to understand the molecular underpinnings of urologic cancer and associated disparities. Dr. Salami is a recipient of several awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, Society of Urologic Oncology Young Investigator, NCI R37 MERIT and 2024 AUA Gold Cystoscope Awards. Most recently, he was named an inaugural Biden White House Cancer Moonshot Scholar. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation. Dr. Salami is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Salami is board certified in Urology.

Nivedita Dhar is a Urologist practicing medicine in Dearborn, Michigan. She has been practicing medicine for over 26 years. Dr. Dhar is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Interstitial Cystitis, Urinary Incontinence, Neurogenic Bladder, Urinary Tract Infection in Children, and Ureteroscopy. Dr. Dhar is board certified in American Board Of Urology. Dr. Dhar is currently accepting new patients.

Jaclyn Milose is a Urologist practicing medicine in Dearborn, Michigan. She has been practicing medicine for over 17 years. Dr. Milose is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Urinary Incontinence, Stress Urinary Incontinence, Acute Cystitis, Ureteroscopy, and Prostatectomy. Dr. Milose is board certified in American Board Of Urology. Dr. Milose is currently accepting new patients.

John Harb is a Urologist practicing medicine in Livonia, Michigan. Dr. Harb is highly rated in 25 conditions, according to our data. His clinical expertise encompasses UPJ Obstruction, Obstructive Uropathy, Urinary Tract Infection in Children, Ureteroscopy, and Prostatectomy.

Gregory Weigler is a Urologist practicing medicine in Livonia, Michigan. Dr. Weigler is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Empyema, Ureteroscopy, and Prostatectomy.

Brent K. Hollenbeck, M.D., M.S. is a practicing urologic oncologist and has been on faculty at the University of Michigan since 2003. A graduate of the Indiana University School of Medicine, Dr. Hollenbeck completed his residency in urology and fellowship training in oncology at the University of Michigan. During the past 5 years, his clinical practice has grown in patient volume, which complements his research imperative. Over this time, he has become increasingly specialized in the care of patients with prostate and bladder cancers. This focus has afforded him the ability to maintain his commitment to research while continuing to deliver cutting-edge, high quality care.Dr. Hollenbeck is currently an Associate Professor of Urology and the Director of the Herbert H. and Grace A. Dow Division of Health Services Research at the University of Michigan. He is firmly committed to training the future leaders in urologic health services research. Further, he strongly believes that populating the surgical specialties with health services researchers will yield long-term benefits to both our specialty and our patients.When he is not engaged in clinical and research pursuits, Brent is a very active swimmer, runner and fly fisherman (especially for steelhead). Perhaps most importantly, however, he enjoys spending the bulk of his free time with his wife and two daughters. The Hollenbecks are avid fans of Michigan athletics and look forward to cheering on the Wolverines on football Saturdays. Dr. Hollenbeck is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy.

Kevin Ginsburg is a Urologist practicing medicine in Dearborn, Michigan. He has been practicing medicine for over 12 years. Dr. Ginsburg is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Oncocytoma, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Ginsburg is board certified in American Board Of Urology. Dr. Ginsburg is currently accepting new patients.

Jeffrey Budzyn is a Urologist practicing medicine in Plymouth, Michigan. Dr. Budzyn is highly rated in 3 conditions, according to our data. His clinical expertise encompasses UPJ Obstruction, Urinary Tract Infection (UTI), Congenital Mesoblastic Nephroma, Lithotripsy, and Nephrectomy.